Skip to main content

Table 1 Clinical and genetic study of psychiatric patients showing Cp < 0.18 g/L and serum Cu levels < 0.88 mg/L

From: Screening of Wilson’s disease in a psychiatric population: difficulties and pitfalls. A preliminary study

Diagnosis

Associated symptoms

Cpa (g/L)

Copperb (mg/L)

Mutations in ATP7B gene

Schizophrenia (n = 13)

Extrapyramidal syndrome (n = 3)

0.10–0.17

0.60–0.88

n = 2 heterozygous mutations

p.His1069Gln c.3207C>A (ex14) (Tanzi 1993) and p.Thr1434Met c.4301C>T (ex 21) [34]

Bipolar disorders (n = 4)

Extrapyramidal syndrome (n = 1)

0.15–0.17

0.72–0.88

ASD (n = 3)

Extrapyramidal syndrome (n = 1)

Kidney failure (n = 1)

0.14–0.18

0.65–0.86

Personality disorders (n = 3)

 

0.13–0.15

0.65–0.84

n = 1

p.Pro1379Ser c.4135C>T (ex 21) [22]

Neurological disorder (n = 2)

Cerebral anoxia (MRI abnormalities in basal ganglia) (n = 1)

0.12–0.16

0.60–0.81

n = 1

p.Thr1434Met c.4301C>T (ex 21) [34]

Behavioral disorder (n = 1)

Mild intellectual deficiency (n = 1)

0.15

0.80

Alcoholism (n = 1)

0.15

0.78

Anorexia nervosa (n = 1)

0.13

0.61

Depressive disorder (n = 1)

0.17

0.87

  1. ASD Autism spectrum disorders
  2. aCp (g/L), Normal values (NV) 0.18–0.32, borderline values (BV) 0.10–0.17, critical values (CV) ≤0.10
  3. bCopper (mg/L), NV 0.88–1.2, BV 0.50–0.87, CV ≤ 0.50